The Latest

This Week in HIV Research: I Screen, You Screen, We All Screen for HPV-Related Cancers

May 23, 2019: How CD4 variables over time affect anal cancer risk; when to consider anal pap smears for women; switching from E/C/F/TAF to ABC/3TC; new data on marijuana use among people with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: HIV Is Not an Obstacle

April 11, 2019: acute syphilis and virologic control; neuropsychological performance after switching off efavirenz; structural LGBTQ stigma and HIV criminalization in U.S. states; lung cancer resection surgery in people with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Science of Risk

Traditional factors vs. HIV-specific factors in non-communicable complications; frailty and fracture risk among women; lipid measurements and coronary risks; new data on efavirenz and birth defects.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Let's Get Real About Treatment Efficacy

Real-world treatment efficacy high, but falls short of trials; parental communication and PrEP awareness among adolescent MSM; immunotherapy feasible in people with HIV and cancer; AIDS-defining illness increases mortality risk in lung cancer patients.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Gender Disparities Among the Formerly Incarcerated

Post-incarceration HIV outcomes worse among women; no drug resistance despite apparent PrEP failure; cost-efficacy of adherence self-management; additional cancers in HIV-positive cancer survivors.

By Barbara Jungwirth and Myles Helfand

New Study From Georgia Sheds Light on Kaposi Sarcoma in Women With HIV

The skin cancer Kaposi Sarcoma (KS) is an HIV-related condition that primarily affects men, but a new cases series presented at IDWeek 2018 in San Francisco highlights the importance of studying women with KS.

By Sony Salzman

This Week in HIV Research: Food, It Does a Body Good

How food insecurity feeds inflammation; racial disparities in HPV16 prevalence; how HIV meds affect pre-existing neurocognitive impairment; central nervous system inflammation in the setting of HIV treatment success.

By Barbara Jungwirth and Myles Helfand

High Rates of Anal HPV Infection in Gay Men Using PrEP in IPERGAY: The Role of Vaccination

A substudy of the high-profile French PrEP study IPERGAY has reported alarmingly high rates of human papillomavirus (HPV) infection in HIV-negative gay men.

By Simon Collins for HIV i-Base

Big 3 Lung Cancer Risk Factors With HIV: Smoking, Low CD4s, Lung Infection

Smoking so dominates the lung cancer risk list that other factors struggle for a small slice of the spotlight.

By Mark Mascolini for The Center for AIDS Information & Advocacy

Lung Cancer Risk and Screening With HIV -- and an Intriguing New Treatment Opportunity

Highly regarded for his contributions to cancer research in people with HIV, Keith M. Sigel, M.D., Ph.D., M.P.H., has led numerous innovative studies on these conditions and others in people with HIV.

By Mark Mascolini for The Center for AIDS Information & Advocacy